SCHEMBL20111291

SCHEMBL20111291

CCCc1ccc2c(c1F)-c1c-2cc(OCC2CCCCC2)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
CTSK P43235 1/20 0.35
PARP10 Q53GL7 2/20 0.33
CYP19A1 P11511 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
SCN9A Q15858 3/20 0.33
PDK2 Q15119 1/20 0.33
SLC6A4 P31645 1/20 0.33
HTR6 P50406 1/20 0.33
C5AR1 P21730 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
SCN5A Q14524 1/20 0.32
PARP15 Q460N3 1/20 0.32
ELANE P08246 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20111654 0.87 BRD4 (0.33) CTSLCTSSCTSK
SCHEMBL20102457 0.87 CTSL (0.33) CTSLCTSSCTSK
SCHEMBL20111296 0.84 CYP19A1 (0.32) PARP10CYP19A1SCN9ASCN5APARP15
SCHEMBL20102467 0.84 PTGDR2 (0.37) SLC6A4HTR6C5AR1
SCHEMBL20111289 0.84 SLC6A4 (0.35) PARP10CYP19A1ALOX5APFEN1PDK2
SCHEMBL20111422 0.84 PARP10 (0.33) PARP10ALOX5APFEN1SCN9APDK2
SCHEMBL20102456 0.81 RIPK1 (0.35) PDK2HTR2AHTR2CHTR2B
SCHEMBL20111277 0.81 HCRTR2 (0.33) ALOX5APFEN1SCN9ASCN5A
SCHEMBL20117601 0.80 SCN9A (0.36) SCN9AHTR2AHTR2CHTR2B
SCHEMBL20111364 0.79 ALOX5AP (0.39) ALOX5APFEN1SCN9ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2019-06-18 US disclosed
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180119009-A1 LIQUID CRYSTAL COMPOUND HAVING BIPHENYLENE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE YBX1, PIEZO1, C1S CTSL 2729/4885CTSS 2436/4885CTSK 2311/4885
US-10323187-B2 Liquid crystal compound having biphenylene, liquid crystal composition and liquid crystal display device YBX1, PIEZO1, C1S CTSL 2729/4885CTSS 2436/4885CTSK 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.